Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCCDezhi Li(Peking University Shenzhen Hospital), Wei Zheng(University of Helsinki)International Journal of OncologyMarch 10, 202310.3892/ijo.2023.5501Cited by 46SaveCiteExport RISWatch citationsRelated PapersLigand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometry|Scientific Reports|2025|1